ATE401095T1 - Mittel zum erhalten und/oder korrigieren der blutglukosekonzentration - Google Patents

Mittel zum erhalten und/oder korrigieren der blutglukosekonzentration

Info

Publication number: ATE401095T1
Authority: AT; Austria
Prior art keywords: blood glucose; maintaining; agents; glucose concentration; polymeric matrix
Prior art date: 2000-05-26

Application number

AT00940275T

Other languages

English (en)

Inventor

Anatoliy Borisovich Davydov

Iouri Tikhonovich Kalinin

Boris Ivanovich Leonov

Tatjana Igorevna Solodkaya

Gennadiy Ljvovich Khromov

Iouri Gennadievich Bobkov

Original Assignee

Frohwitter Bernhard

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-26

Filing date

2000-05-26

Publication date

2008-08-15

2000-05-26 Application filed by Frohwitter Bernhard filed Critical Frohwitter Bernhard

2008-08-15 Application granted granted Critical

2008-08-15 Publication of ATE401095T1 publication Critical patent/ATE401095T1/de

Links

WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract 2
239000008280 blood Substances 0.000 title abstract 2
210000004369 blood Anatomy 0.000 title abstract 2
239000008103 glucose Substances 0.000 title abstract 2
239000003795 chemical substances by application Substances 0.000 title 1
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 4
239000011159 matrix material Substances 0.000 abstract 3
102000004877 Insulin Human genes 0.000 abstract 2
108090001061 Insulin Proteins 0.000 abstract 2
229920001600 hydrophobic polymer Polymers 0.000 abstract 2
229940125396 insulin Drugs 0.000 abstract 2
238000002360 preparation method Methods 0.000 abstract 2
108010033040 Histones Proteins 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Dermatology (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating Or Analysing Biological Materials (AREA)
Sampling And Sample Adjustment (AREA)
Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

AT00940275T 2000-05-26 2000-05-26 Mittel zum erhalten und/oder korrigieren der blutglukosekonzentration ATE401095T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/EP2000/004826 WO2001091784A1 (en)	2000-05-26	2000-05-26	Means for maintenance and/or correction of glucose concentration in blood

Publications (1)

Publication Number	Publication Date
ATE401095T1 true ATE401095T1 (de)	2008-08-15

Family

ID=8163961

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00940275T ATE401095T1 (de)	2000-05-26	2000-05-26	Mittel zum erhalten und/oder korrigieren der blutglukosekonzentration

Country Status (6)

Country	Link
US (1)	US7259139B1 (de)
EP (1)	EP1289542B1 (de)
AT (1)	ATE401095T1 (de)
AU (1)	AU2000255261A1 (de)
DE (1)	DE60039540D1 (de)
WO (1)	WO2001091784A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7687608B2 (en)	2005-10-19	2010-03-30	Smartcells, Inc.	Methods for reducing the mitogenicity of lectin compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2504408B1 (fr) *	1981-04-24	1986-02-14	Couvreur Patrick	Procede de preparation de particules submicroscopiques, particules ainsi obtenues et compositions pharmaceutiques les contenant
SU1011126A1 (ru) *	1981-07-14	1983-04-15	Всесоюзный научно-исследовательский и испытательный институт медицинской техники	Средство дл лечени сахарного диабета
US4666704A (en) *	1985-05-24	1987-05-19	International Minerals & Chemical Corp.	Controlled release delivery system for macromolecules
IE61651B1 (en) *	1990-07-04	1994-11-16	Zambon Spa	Programmed release oral solid pharmaceutical dosage form
US6277410B1 (en) *	1992-10-08	2001-08-21	Supratek Pharma Inc.	Copolymer compositions for oral delivery
WO1997005185A2 (en) *	1995-07-28	1997-02-13	Focal, Inc.	Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents
SE505146C2 (sv) *	1995-10-19	1997-06-30	Biogram Ab	Partiklar för fördröjd frisättning

2000
- 2000-05-26 AT AT00940275T patent/ATE401095T1/de not_active IP Right Cessation
- 2000-05-26 DE DE60039540T patent/DE60039540D1/de not_active Expired - Lifetime
- 2000-05-26 US US10/297,004 patent/US7259139B1/en not_active Expired - Lifetime
- 2000-05-26 EP EP00940275A patent/EP1289542B1/de not_active Expired - Lifetime
- 2000-05-26 AU AU2000255261A patent/AU2000255261A1/en not_active Abandoned
- 2000-05-26 WO PCT/EP2000/004826 patent/WO2001091784A1/en not_active Ceased

Also Published As

Publication number	Publication date
DE60039540D1 (de)	2008-08-28
US7259139B1 (en)	2007-08-21
WO2001091784A1 (en)	2001-12-06
AU2000255261A1 (en)	2001-12-11
EP1289542A1 (de)	2003-03-12
EP1289542B1 (de)	2008-07-16

Similar Documents

Publication	Publication Date	Title
GEP20022804B (en)	2002-09-25	Erythropoietin Derivatives
BR9916592A (pt)	2002-01-22	Artigo de cuidado pessoal sequestrante de irritante da pele e método de sequestrar irritantes da pele
TR200002355T2 (tr)	2000-11-21	2-(Pürin-9-il)tetrahidrofüran-3,4-diol türevleri
BR9910251A (pt)	2001-01-02	Estimulação hematopoiética
SV2002000245A (es)	2002-01-15	Oxazolidinonas substituidas y su uso ref. lea 34122-sv
ES2176502T3 (es)	2002-12-01	Derivados de hidroxilamina utiles para mejorar la pproduccion de chaperonas moleculares su su preparacion.
BR0207775A (pt)	2004-03-30	Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
CY1108544T1 (el)	2014-04-09	Παραγωγα πυραζολιου, συνθεσεις που περιεχουν τετοιες ενωσεις και μεθοδοι χρησης
BR0014652A (pt)	2003-06-10	Fabricação de conjugados de agente terapêutico-poliglutamato
CY1108165T1 (el)	2014-02-12	ΤΟΠΙΚΗ ΧΡΗΣΗ ΔΟΛΩΜΑΤΟΣ NF-κΒ ΓΙΑ ΤΗΝ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΤΗΣ ΑΤΟΠΙΚΗΣ ΔΕΡΜΑΤΙΤΙΔΑΣ
ATE267613T1 (de)	2004-06-15	Arzneimittel und deren verwendung
ATE308999T1 (de)	2005-11-15	Intrazellulare expression von carboxypeptidase g2 in enzyme-prodrug-therapie
BRPI0414979A (pt)	2006-11-21	preparação sólida
ATE253820T1 (de)	2003-11-15	Wirkstoffhaltige komposition sowie deren herstellung und verwendung
DE60314722D1 (de)	2007-08-16	Zusammensetzung für die pharmazeutische oder dietätische verwendung zur bekämpfung von haarausfall
DE59407457D1 (de)	1999-01-21	Blockierung der anlagerung von keimen an menschliche zellen
ATE478662T1 (de)	2010-09-15	Arzneilösungen enthaltend modafinilverbindungen
BRPI0412989A (pt)	2006-10-03	combinação farmacêutica útil para mobilização de célula-tronco
ATE226065T1 (de)	2002-11-15	Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
BG105779A (bg)	2002-04-30	Човешки антибиотични протеини
ATE401095T1 (de)	2008-08-15	Mittel zum erhalten und/oder korrigieren der blutglukosekonzentration
DE59304087D1 (de)	1996-11-14	Placentaextrakt und Verfahren zu seiner Herstellung
DE3767731D1 (de)	1991-03-07	Prostacyclinanalog, dieses als aktives bestandteil enthaltendes, den blutumlauf verbesserndes mittel und gegen magengeschwuere wirkendes mittel.
ATE353642T1 (de)	2007-03-15	Verwendung von hypoestoxiden als antiparasitäre mittel
DK1019037T3 (da)	2001-10-01	Lægemiddel indeholdende delta-aminolevulinsyre

Legal Events

Date	Code	Title	Description
2009-01-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties